KTRAKintara Therapeutics, Inc.

Nasdaq kintara.com


$ 0.13 $ -0.01 (-7.25 %)    

Tuesday, 14-May-2024 15:26:41 EDT
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 0.128
$ 0.13
$ 0.00 x 0
$ 0.00 x 0
$ 0.13 - $ 0.13
$ 0.08 - $ 5.60
5,074,701
na
214,439
$ 0.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-14-2024 12-31-2023 10-Q
3 11-13-2023 09-30-2023 10-Q
4 09-18-2023 06-30-2023 10-K
5 05-11-2023 03-31-2023 10-Q
6 02-14-2023 12-31-2022 10-Q
7 11-09-2022 09-30-2022 10-Q
8 09-27-2022 06-30-2022 10-K
9 05-13-2022 03-31-2022 10-Q
10 02-11-2022 12-31-2021 10-Q
11 11-15-2021 09-30-2021 10-Q
12 09-28-2021 06-30-2021 10-K
13 05-13-2021 03-31-2021 10-Q
14 02-12-2021 12-31-2020 10-Q
15 11-12-2020 09-30-2020 10-Q
16 09-18-2020 06-30-2020 10-K
17 05-13-2020 03-31-2020 10-Q
18 02-13-2020 12-31-2019 10-Q
19 11-13-2019 09-30-2019 10-Q
20 09-09-2019 06-30-2019 10-K
21 05-14-2019 03-31-2019 10-Q
22 02-11-2019 12-31-2018 10-Q
23 11-13-2018 09-30-2018 10-Q
24 09-24-2018 06-30-2018 10-K
25 05-15-2018 03-31-2018 10-Q
26 02-14-2018 12-31-2017 10-Q
27 11-09-2017 09-30-2017 10-Q
28 09-27-2017 06-30-2017 10-K
29 05-12-2017 03-31-2017 10-Q
30 02-10-2017 12-31-2016 10-Q
31 11-10-2016 09-30-2016 10-Q
32 09-13-2016 06-30-2016 10-K
33 05-12-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-Q
35 11-16-2015 09-30-2015 10-Q
36 09-03-2015 06-30-2015 10-K
37 05-15-2015 03-31-2015 10-Q
38 02-12-2015 12-31-2014 10-Q
39 11-07-2014 09-30-2014 10-Q
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 kintara-therapeutics-q3-2024-gaap-eps-005

Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(0.05) per share.

 why-byrna-technologies-shares-are-trading-higher-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-ex...

 why-staar-surgical-shares-are-trading-higher-by-around-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong prelimi...

 nasdaq-gains-75-points-acuity-brands-posts-upbeat-earnings

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3% on Wednesday. The Dow traded up ...

 why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

 crude-oil-moves-higher-ism-services-pmi-falls-in-march

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 0.5% on Wednesday. The Dow traded up ...

 us-stocks-edge-lower-private-employment-tops-views

U.S. stocks traded lower this morning, following the release of ADP jobs data on Wednesday. Following the market opening Wedne...

 why-kintara-therapeutics-shares-are-gaining-today

Kintara Therapeutics shares surge premarket as the company announces definitive merger agreement with TuHURA Biosciences, focus...

 kintara-therapeutics-and-tuhura-biosciences-agree-to-merge-in-an-all-stock-transaction

TuHURA is planning to advance a single Phase 3 trial for IFx-2.0 personalized cancer vaccine as adjunctive therapy with Keytr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION